Related Experiment Videos
Ependymoma: ultrastructural studies of two cases
1Laboratory Service, Department of Veterans Affairs Medical Center, Washington, DC 20422.
Ultrastructural Pathology
|March 1, 1991
Summary
This study reports unusual ultrastructural findings in two ependymomas, including unique vacuoles and cell structures. Some tumor cells in a third ventricle ependymoma showed differentiation towards ependymal tanycytes.
Area of Science:
- Neuro-oncology
- Cellular Ultrastructure
- Neoplastic Pathology
Background:
- Ependymomas are tumors arising from ependymal cells, the cells lining the ventricles of the brain and the central canal of the spinal cord.
- Understanding ependymoma ultrastructure is crucial for accurate diagnosis and classification, particularly for differentiating subtypes and grades.
- Previous studies have characterized typical ependymoma ultrastructural features, but unusual findings can offer insights into cell differentiation and tumor biology.
Observation:
- Case 1 (Grade I, fourth ventricle ependymoma) exhibited intracytoplasmic vacuoles containing microrosettes with abnormal zonulae adherentiae.
- Case 2 (recurrent Grade III, third ventricle ependymoma) showed dense-core vesicles and parallel microtubule arrays in tumor cell processes within perivascular pseudorosettes.
- These observed ultrastructural features were not present in normal mammalian ependymal cells.
Findings:
- The unusual vacuoles in Case 1 suggest potential complex intracellular structures or degenerative processes.
- The dense-core vesicles and microtubule arrays in Case 2 are characteristic of ependymal tanycytes, a specialized ependymal cell type.
- These findings indicate potential tanycytic differentiation in the third ventricle ependymoma.
Implications:
- The presence of tanycyte-like structures in a third ventricle ependymoma suggests a possible link between tumor cell differentiation and the specific microenvironment of the third ventricle.
- Unusual ultrastructural findings can serve as diagnostic markers and may influence prognostic assessment of ependymomas.
- Further research into ependymoma heterogeneity and cell differentiation pathways could lead to novel therapeutic strategies.